Biosimilars: Rise In US FDA Approvals Means Lower Or Flat User Fees In FY 2020

 
• By Sue Sutter
  
The titan called Atlas is carrying the world on his shoulders. Greek mythotology figure as part of the historical train station roof built in 1888 in Frankfurt, Germany. - Image
Sponsors with approved biosimilars will shoulder more of the burden for funding the agency’s user fee program in FY 2020. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics